J Korean Vasc Surg Soc.  1998 Apr;14(1):51-57.

Hemangioma and Arteriovenous Malformation: Percutaneous Sclerotherapy and Endovascular Treatment

• Hwang DH
• Chung JW
• Park JH

Abstract

PURPOSE: This study was done to evaluate the efficacy and safety of percutaneous sclerotherapy or endovascular treatment of hemangioma and venous malformation.
METHODS
9 interventional procedures were performed in 7 patients whose age ranged from 16 years to 52 years. Five of these patients had arteriovenous malformation, the remaining had hemangioma and venous malformation. N-buty1-2-cyanoacrylate was injected percutaneously in 4 procedures and intraarterially in one procedure. Ethanol with lipiodol(10%) was injected percutaneously in 2 procedures. 1valon particle was embolized intraarterial in 1 procedure.
RESULTS
N-buty1-2-cyanoacrylate injection, Contour arterial embolozation, Etanole with lipiodo1, sclerotherapy followed by physician and was judged beneficial in 7 of 7 patients. One pateint had minor complication(skin ulcer) but no long term sequelae.
CONCLUSIONS
Percutaneous sclerotherapy and endovascular treatment, either or before surgery is a safe and effective method of managing hemangioma and arteriovenous malformations.

Keyword

Hemangioma; Arteriovenous malformation; Sclerotherapy; Endovascular

MeSH Terms

Arteriovenous Malformations*
Ethanol
Hemangioma*
Humans
Sclerotherapy*
Ethanol